Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 20/20 | 1.00 |
| ▸ | EGFR | P00533 | 5/20 | 1.00 |
| ▸ | ABL1 | P00519 | 4/20 | 0.82 |
| ▸ | ABL2 | P42684 | 4/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8108635 | 0.95 | SRC (0.90) | SRCEGFRABL1ABL2 | |
| SCHEMBL8098919 | 0.94 | SRC (0.90) | SRCEGFRABL1ABL2 | |
| SCHEMBL28945343 | 0.93 | SRC (0.87) | SRCEGFRABL1ABL2 | |
| SCHEMBL15708503 | 0.93 | SRC (0.87) | SRCEGFRABL1ABL2 | |
| SCHEMBL6465483 | 0.93 | SRC (0.87) | SRCEGFRABL1ABL2 | |
| SCHEMBL20351767 | 0.93 | SRC (0.88) | SRCEGFRABL1ABL2 | |
| SCHEMBL20351683 | 0.92 | SRC (0.87) | SRCEGFRABL1ABL2 | |
| SCHEMBL8107904 | 0.92 | SRC (1.00) | SRCEGFRABL1ABL2 | |
| SCHEMBL8098911 | 0.90 | SRC (1.00) | SRCEGFRABL1ABL2 | |
| SCHEMBL7853084 | 0.90 | SRC (0.81) | SRCEGFRABL1ABL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6051577-A | TYROSINE INHIBITORS; BONE DISORDERS | NOVARTIS AG (CH) | 2000-04-18 | — | — | US | disclosed |